Commonwealth Equity Services’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $86K | Hold |
90,864
| – | – | ﹤0.01% | 4091 |
|
2025
Q1 | $42K | Sell |
90,864
-10,284
| -10% | -$4.75K | ﹤0.01% | 4083 |
|
2024
Q4 | $75K | Sell |
101,148
-7,586
| -7% | -$5.63K | ﹤0.01% | 3945 |
|
2024
Q3 | $171K | Buy |
108,734
+7,600
| +8% | +$12K | ﹤0.01% | 3760 |
|
2024
Q2 | $170K | Buy |
101,134
+5,950
| +6% | +$10K | ﹤0.01% | 3688 |
|
2024
Q1 | $228K | Buy |
95,184
+61,000
| +178% | +$146K | ﹤0.01% | 3524 |
|
2023
Q4 | $52K | Sell |
34,184
-5,385
| -14% | -$8.19K | ﹤0.01% | 3754 |
|
2023
Q3 | $43K | Buy |
39,569
+24,400
| +161% | +$26.5K | ﹤0.01% | 3672 |
|
2023
Q2 | $35K | Buy |
15,169
+1,100
| +8% | +$2.54K | ﹤0.01% | 3704 |
|
2023
Q1 | $34 | Sell |
14,069
-10,400
| -43% | -$25 | ﹤0.01% | 3617 |
|
2022
Q4 | $46K | Sell |
24,469
-107
| -0.4% | -$201 | ﹤0.01% | 3524 |
|
2022
Q3 | $58K | Hold |
24,576
| – | – | ﹤0.01% | 3463 |
|
2022
Q2 | $45K | Buy |
24,576
+10,300
| +72% | +$18.9K | ﹤0.01% | 3501 |
|
2022
Q1 | $29K | Hold |
14,276
| – | – | ﹤0.01% | 3632 |
|
2021
Q4 | $56K | Hold |
14,276
| – | – | ﹤0.01% | 3521 |
|
2021
Q3 | $68K | Buy |
14,276
+107
| +0.8% | +$510 | ﹤0.01% | 3469 |
|
2021
Q2 | $65K | Hold |
14,169
| – | – | ﹤0.01% | 3441 |
|
2021
Q1 | $83K | Hold |
14,169
| – | – | ﹤0.01% | 3296 |
|
2020
Q4 | $48K | Buy |
+14,169
| New | +$48K | ﹤0.01% | 3131 |
|
2020
Q1 | – | Sell |
-16,461
| Closed | -$68K | – | 2904 |
|
2019
Q4 | $68K | Hold |
16,461
| – | – | ﹤0.01% | 2778 |
|
2019
Q3 | $49K | Buy |
16,461
+4,746
| +41% | +$14.1K | ﹤0.01% | 2741 |
|
2019
Q2 | $73K | Sell |
11,715
-1,631
| -12% | -$10.2K | ﹤0.01% | 2663 |
|
2019
Q1 | $74K | Sell |
13,346
-8,172
| -38% | -$45.3K | ﹤0.01% | 2633 |
|
2018
Q4 | $142K | Sell |
21,518
-6,000
| -22% | -$39.6K | ﹤0.01% | 2424 |
|
2018
Q3 | $293K | Buy |
27,518
+203
| +0.7% | +$2.16K | ﹤0.01% | 2186 |
|
2018
Q2 | $328K | Buy |
27,315
+2,600
| +11% | +$31.2K | ﹤0.01% | 2044 |
|
2018
Q1 | $211K | Buy |
24,715
+2,135
| +9% | +$18.2K | ﹤0.01% | 2360 |
|
2017
Q4 | $223K | Sell |
22,580
-2,987
| -12% | -$29.5K | ﹤0.01% | 2288 |
|
2017
Q3 | $314K | Buy |
25,567
+1,000
| +4% | +$12.3K | ﹤0.01% | 1948 |
|
2017
Q2 | $404K | Sell |
24,567
-900
| -4% | -$14.8K | ﹤0.01% | 1708 |
|
2017
Q1 | $365K | Buy |
25,467
+5,069
| +25% | +$72.7K | ﹤0.01% | 1722 |
|
2016
Q4 | $282K | Sell |
20,398
-5,929
| -23% | -$82K | ﹤0.01% | 1811 |
|
2016
Q3 | $476K | Buy |
26,327
+4,323
| +20% | +$78.2K | ﹤0.01% | 1408 |
|
2016
Q2 | $316K | Sell |
22,004
-6,989
| -24% | -$100K | ﹤0.01% | 1624 |
|
2016
Q1 | $346K | Sell |
28,993
-5,800
| -17% | -$69.2K | ﹤0.01% | 1539 |
|
2015
Q4 | $463K | Sell |
34,793
-833
| -2% | -$11.1K | ﹤0.01% | 1320 |
|
2015
Q3 | $383K | Buy |
35,626
+20,086
| +129% | +$216K | ﹤0.01% | 1394 |
|
2015
Q2 | $125K | Sell |
15,540
-3
| -0% | -$24 | ﹤0.01% | 2048 |
|
2015
Q1 | $103K | Buy |
15,543
+4,357
| +39% | +$28.9K | ﹤0.01% | 2055 |
|
2014
Q4 | $71K | Buy |
11,186
+4,206
| +60% | +$26.7K | ﹤0.01% | 2002 |
|
2014
Q3 | $69K | Hold |
6,980
| – | – | ﹤0.01% | 1994 |
|
2014
Q2 | $79K | Buy |
6,980
+2,072
| +42% | +$23.5K | ﹤0.01% | 1955 |
|
2014
Q1 | $59K | Buy |
4,908
+2,465
| +101% | +$29.6K | ﹤0.01% | 1925 |
|
2013
Q4 | $31K | Hold |
2,443
| – | – | ﹤0.01% | 1894 |
|
2013
Q3 | $41K | Sell |
2,443
-143
| -6% | -$2.4K | ﹤0.01% | 1816 |
|
2013
Q2 | $39K | Buy |
+2,586
| New | +$39K | ﹤0.01% | 1750 |
|